Clin2
NCT07235228Possibly a fitRecruiting

Synbiotic supplement for irritable bowel syndrome

Irritable Bowel Syndrome

Part of Digestive system clinical trials.

This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have been diagnosed with irritable bowel syndrome (IBS) that is moderate or severe.
  • You have not taken any probiotic products (like supplements or yogurts with live bacteria) in the past 3 months.
  • You have not taken antibiotics in the past 3 months.
  • You do not have other serious health conditions such as cancer, uncontrolled diabetes, heart, liver, or kidney problems, or a major breathing disorder.
  • You do not have other bowel diseases like Crohn's disease, ulcerative colitis, or celiac disease.
  • You are not pregnant, breastfeeding, or planning to become pregnant in the next 3 months.
  • You do not have lactose intolerance.
  • You are not taking blood thinners (anticoagulants).
  • You have not taken any motility drugs or fiber supplements in the 2 weeks before the study starts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07235215Recruiting
Testing Vivatlac for Irritable Bowel Syndrome

This study tests a product called Vivatlac to see if it can help people with Irritable Bowel Syndrome (IBS). If you have moderate-to-severe IBS and haven't taken probiotics or antibiotics recently, you may be able to join.

Jarocin
NCT06433180Not yet recruiting· Phase 3
Fecal transplant for severe irritable bowel syndrome

This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.

Bobigny
NCT06960941Not yet recruiting
Dietary supplement for irritable bowel syndrome with metabolic issues

This study tests whether a dietary supplement can help people who have both irritable bowel syndrome (IBS) and signs of metabolic syndrome (like high blood sugar or high blood pressure). It might ease your belly symptoms and improve your overall metabolic health.

Roma
NCT07716852Not yet recruiting
Testing a probiotic supplement for irritable bowel syndrome

This study tests a dietary supplement called Enzymax DuoBiotics to see if it helps ease irritable bowel syndrome (IBS) symptoms like belly pain and irregular bowel habits. If you have IBS and are looking for a non-drug option, this may be a good fit.

NCT07039747Recruiting· Phase 2
Can a dietary supplement help people with irritable bowel syndrome?

This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.

Rouen, France
NCT07475299Not yet recruiting
Gut health supplement for irritable bowel syndrome

This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.

Cluj-Napoca

Hear when a new Irritable Bowel Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.